Actively Recruiting
French Cohort of Myocardial Infarction Evaluation
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-25
30000
Participants Needed
1
Research Sites
1567 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
N
Novartis
Collaborating Sponsor
AI-Summary
What this Trial Is About
Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively. The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.
CONDITIONS
Official Title
French Cohort of Myocardial Infarction Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Myocardial infarction within 48 hours of symptom onset, confirmed by increased or falling troponin or CPKMB with at least one of the following: symptoms of myocardial ischemia, pathological Q waves, or ST-T changes compatible with ischemia
- Written consent to participate
- Covered by French medical insurance (S�curit� Sociale)
You will not qualify if you...
- Heart attack caused by a medical procedure within 48 hours prior to admission
- Diagnosis of acute myocardial infarction ruled out in favor of another condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Bichat, AP-HP
Paris, France, 75018
Actively Recruiting
Research Team
T
Tabassome SIMON
CONTACT
P
Philippe Gabriel STEG
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here